| Send2Press.com • Today is Friday, July 03, 2009 | A Member of the Neotrope News Network |  |
 Search Send2Press.com: |
|
|
|
PRESS RELEASE : U.S. and World News :
Business :
Management Changes
News
|
|||||||||||||||||||||||||
|
ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald
Thu, 30 Oct 2008, 16:53:04 EDT Edited by Carly Zander    SILVER LAKE, Ohio, Oct. 30 (SEND2PRESS NEWSWIRE) -- ACE Vision Group, Inc. today announced the appointment of Marguerite McDonald, M.D. as Global Medical Director. Dr. McDonald is a cornea/refractive/anterior segment specialist for Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan and an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.  Dr. McDonald is a staff physician at Manhattan Eye, Ear and Throat Hospital in New York City, as well as at the Island Eye Center in Carle Place, New York. Dr. McDonald received her medical degree from Columbia University College of Physicians and Surgeons, followed by an internship at Lenox Hill Hospital and ophthalmology residency at Manhattan Eye, Ear and Throat Hospital/Cornell, both in New York City, and a fellowship in corneal and external diseases with Dr. Herbert E. Kaufman at the LSU Eye Center in New Orleans. Well known in the field of refractive surgery, Dr. McDonald has published 497 abstracts, 79 books and book chapters, 49 interviews/panel discussions/CD ROMs/videos, and 180 peer reviewed and 294 non-peer reviewed articles on various refractive topics. Dr. McDonald has been the principal investigator of three National Eye Institute grants for the study of refractive surgery. In New Orleans, Dr. McDonald headed the research team investigating the use of the excimer laser for the correction of optical error, and in 1987, performed the world's first excimer laser treatment to eliminate or reduce the need for glasses and contact lenses. In 1993, she performed the world's first excimer laser surgeries for farsightedness. Dr. McDonald has been honored by selection to the editorial boards of several publications, including the Journal of Cataract and Refractive Surgery and Refractive and Corneal Surgery. In 1997 she was elected to the Executive Committee of the prestigious American Society of Cataract and Refractive Surgery (ASCRS), and was elected its first female president for the 2002-2003 term. Dr. McDonald is the president for the 2008-2010 term of the International Society of Refractive Surgery of the American Academy of Ophthalmology, the largest refractive surgery society in the world; she is the first female president of this organization. ACE Vision Group, Inc. President and CEO Patrick H. Witham stated: "In Dr. McDonald, ACE is adding a highly-skilled, top-notch industry leader to further strengthen our clinical team. It is her unprecedented level of expertise that makes her an ideal fit for ACE Vision Group as we work diligently to successfully advance this technology through clinical development and toward the market." ACE Vision Group, Inc. Chief Scientific Officer Dr. AnnMarie Hipsley commented: "Marguerite has an amazing wealth of knowledge and depth of experience as a liaison between the FDA and companies delivering innovative technology. I am confident that her participation will be a catalyst to the great success that lays ahead for AVG." About ACE Vision Group, Inc. Headquartered in Silver Lake, Ohio, and a branch office in Eugene, Oregon, ACE Vision Group Inc. is an ophthalmic medical device company that was established in 2006 to develop and market proprietary technology to restore dynamic accommodation in an aging eye for patients seeking to reduce or eliminate their dependency on reading glasses. More information: www.acevisiongroup.com. For more information about ACE Vision Group, Inc. call AVG Public Relations at (866) 596-2188 or email: info@acevisiongroup.com. All trademarks are property of their respective owners.
NEWS SOURCE: ACE Vision Group, Inc.
Send2Press® is the originating wire service for this story. Terms of Use
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE, WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE (SEND2PRESS® NEWSWIRE).
Latest News from Send2Press Newswire:
Additional News on Similar Topics:
|
More News from this Company
Reader Resources
Main Send2Press® News Channels
Subscribe to Weekly News Alert
from Send2Press Newswire
|
|
|||||||||||||||||||||||
MEDIA READS (by media and public, as of today): 1516 times (2 today, 14 this week,
5 this month, 693 this year)
Site Design and Content is Copr. © 1983 - 2009 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Our Services | Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Headline Feeds | Podcast | PR News Channels | Top-10 News | Success Stories | PRTRax™ Reader Tracking | Targeted News Distribution | Internet Marketing Services | Order PR Services | Terms of Service (TOS) |
|||||||||||||||||||||||||
Google
Reddit
Diigo
Delicious
Yahoo!
Digg
Blinklist
Blogmarks
Mixx
Facebook
Newsvine
